Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: A systematic review and meta-analysis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Santin, Miguel ^a,b,c   Muñoz, Laura ^a   Rigau, David ^d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Iberoamerican Cochrane Center   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CD4 LYMPHOCYTE COUNT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; META ANALYSIS; MIXED INFECTION; PATIENT ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUBERCULOSIS; IMMUNOLOGY; METHODOLOGY; QUALITY CONTROL;

ADULT; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84857749048     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032482     Document Type: Review

References (62)

1. Giraldi E, Antonucci G, Vanacore P, Palmieri F, Matteelli A, et al. (2004) Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy. Eur Respir J 24: 11-17.
2. World Health Organization website. Available: http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf. Accessed 2011 September 22.
3. Centers for Disease Control and Prevention (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR Early Release 58: 1-207.
4. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, et al. (1993) Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 148: 1292-7.
5. Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, et al. (1993) Tuberculin and anergy testing in HIV seropositive and HIV seronegative persons. Pulmonary complications of HIV infection study group. Ann Intern Med 119: 185-193.
6. Santin-Cerezales M, Dominguez-Benitez J, (2011) Diagnosis of tuberculosis infection using interferon-γ-based assays. Enferm Infecc Microbiol Clin 29 (Supl 1): 26-33.
7. Pai M, Zwerling A, Menzies D, (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184.
8. Diel R, Loddenkemper R, Nienhaus A, (2010) Evidence-based comparison of commercial interferon-γ release assays for detecting active TB. A metaanalysis. Chest 137: 952-968.
9. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, et al. (2011) Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 37: 100-111.
10. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, et al. (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 56: 230-238.
11. Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, et al. (2011) Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. Clin Infect Dis 204: S1120-1129.
12. Chen J, Zhang R, Wang J, Liu L, Zheng Y, et al. (2011) Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis. PLoS ONE 6: e26827.
13. World Health Organization website. Available: http://whqlibdoc.who.int/hq/2011/WHO_HTM_TB_2011.17_eng.pdf. Accessed: 2011 December 15.
14. Moher D, Liberati A, Tetzlaff J, Altman DG, and the PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6: e000097.
15. Whiting PF, Weswood ME, Rutjes AWS, Reitsma JB, Bossuyt PNM, et al. (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6: 9.
16. Wells GA, Shea B, O'Connell D, Peterson J, Weich V, The Newcasttle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed 2011 August 16.
17. World Health Organization website. Available: http://www.who.int/tb/country/data/profiles/en/index.html. Accessed 2011 August 16.
18. Wallace BC, Schmid CH, Lau J, Trikalinos TA, (2009) Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 9: 80.
19. Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, et al. (2006) Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 44: 2844-2850.
20. Chee CB, Gan SH, Khinmar KW, Barkham TM, Koh CK, et al. (2008) Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol 46: 1935-1940.
21. Markova R, Todorova Y, Drenska R, Elenkov I, Yankova M, et al. (2009) Usefulness of interferon-gamma release assays in the diagnosis of tuberculosis infection in HIV-infected patients in Bulgaria. Biotechnol Biotechnol Equip 23: 1103-1108.
22. Aichelburg MC, Rieger A, Breitenecker F, Pfistershammer K, Tittes J, et al. (2009) Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 48: 954-962.
23. Kabeer BSA, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, et al. (2009) Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One 4: e5718.
24. Leidl L, Mayanja-Kizza H, Sotgiu G, Baseke J, Ernst M, et al. (2010) Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Resp J 35: 619-626.
25. Garcia-Gasalla M, Fernández-Baca V, Mir Viladrich I, Cifuentes-Luna C, Campins-Roselló A, et al. (2010) Quantiferon-TB-Gold In-Tube test in the diagnosis of pulmonary and extra-pulmonary tuberculosis. Enferm Infecc Microbiol Clin 28: 685-689.
26. Sauzullo I, Mengoni F, Scribo R, Valesini G, Potenza C, et al. (2010) Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis 14: 834-840.
27. Bua A, Molicotti P, Ruggeri M, Madeddu G, Ferrandu G, et al. (2011) Interferon-γ release assay in people infected with human immunodeficiency virus. Clin Microbiol Infect 17: 402-404.
28. Kabeer BS, Sikhamani R, Raja A, (2010) Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 24: 323-325.
29. Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, et al. (2010) Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia. BMC Infect Dis 10: 354.
30. Veldsman C, Kock MM, Rossouw T, Nieuwoudt M, Maeurer M, et al. (2009) QuantiFERON-TB GOLD ELISA assay for the detection of Mycobacterium tuberculosis-specific antigens in blood specimens of HIV-positive patients in a high-burden country. FEMS Immunol Med Microbiol 57: 269-273.
31. Ling DI, Pai M, Davids V, Brunet L, Lenders L, et al. (2011) Are interferon-γ release assays useful for active tuberculosis in a high-burden setting? Eur Respir J 38 (3): 649-56.
32. Rangaka MX, Gideon HP, Wilkinson KA, Pai M, Mwansa-Kambafilwe J, et al. (2012) No discriminatory value of interferon release added to smear negative HIV-tuberculosis algorithms. Eur Respir J 39: 163-171.
33. Dheda K, van Zyl-Smit RN, Meldau R, Symons G, Khalfey H, et al. (2009) Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax 64: 847-853.
34. Oni T, Patel J, Gideon HP, Seldon R, Wood K, et al. (2010) Enhanced diagnosis of HIV-associated tuberculosis by relating T-SPOT.TB and CD4 counts. Eur Resp J 36: 594-600.
35. Tan CK, Hung CC, Lai CC, Liao CH, Chou CH, et al. (2010) Diagnosis of active tuberculosis by enzyme-linked immunospot assay for interferon-gamma in HIV-infected patients. J Acquir Immune Defic Syndr 53: 546-547.
36. Cattamanchi A, Ssewenyana I, Davis JL, Huang L, Worodria W, et al. (2010) Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis 10: 75.
37. Chen J, Sun J, Zhang R, Liu L, Zheng Y, et al. (2011) T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected patients with advanced immunodeficiency. AIDS Res Hum Retroviruses 27: 289-294.
38. Vincenti D, Carrara S, Butera O, Bizzoni F, Casetti R, et al. (2007) Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol 150: 91-98.
39. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, et al. (2006) Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Research 7: 56-64.
40. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, et al. (2007) Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 175: 737-742.
41. Latorre I, Martinez-Lacasa X, Font R, Lacoma A, Puig J, et al. (2010) IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection. BMC Infect Dis 10: 348.
42. Idh J, Abate E, Westman A, Elias D, Janols H, et al. (2010) Kinetics of the QuantiFERON-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease. Scand J Infect Dis 42: 650-657.
43. Santin M, Casas S, Saumoy M, Andreu A, Moure R, et al. (2011) Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons. Diagn Clin Microbiol Infect Dis 69: 59-65.
44. Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, et al. (2007) Utility of QuantiFERON-TB Gold In-Tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis 11: 1190-1995.
45. Raby E, Moyo M, Devendra A, Banda J, De Haas P, et al. (2008) The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS ONE 6: e2489.
46. Domínguez J, Ruiz-Manzano J, De Souza-Galvão M, Latorre I, Milà C, et al. (2008) Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol 15: 168-171.
47. Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, et al. (2009) Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 9: 15.
48. Richeldi L, Losi M, D'Amico R, Luppi M, Ferrari A, et al. (2009) Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 136: 198-204.
49. Shanaube K, Hargreavesn J, Fielding K, Schaap A, Lawrence KA, et al. (2011) Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PLoS One 6: e18206.
50. Dheda K, Lalvani A, Miller RF, Scott G, Booth H, et al. (2005) Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 19: 2038-2041.
51. Hoffmann M, Reichmuth M, Fantelli K, Schoch OD, Fierz W, et al. (2007) Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. AIDS 21: 390-392.
52. Clark SA, Martin SL, Pozniak A, Steel A, Ward B, et al. (2007) Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 150: 238-240.
53. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, et al. (2007) Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 175: 514-520.
54. Mandalakas AM, Hesseling AC, Chegou NN, Kirchner HL, Zhu X, et al. (2008) High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 12: 417-423.
55. Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, et al. (2008) Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 22: 2471-2479.
56. Rivas I, Latorre I, Sanvisens A, Dominguez J, Tort J, et al. (2009) Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers. Epidemiol Infect 137: 1342-1347.
57. Barth RE, Mudrikova T, Hoepelman AI, (2008) Interferon-gamma release assays (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics? Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting. Int J Infect Dis 12 (6): e1-e6.
58. Hougardy JM, Place S, Hildebrand M, Drowart A, Debrie AS, et al. (2007) Regulatory T Cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med 176: 409-416.
59. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, et al. (2012) Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 12: 45-55.
60. Shanaube K, De Haas P, Schaap A, Moyo M, Kosloff B, et al. (2010) Intra-assay reliability and robustness of QuantiFERON®-TB Gold In-Tube test in Zambia. Int J Tuberc Lung Dis 14: 828-833.
61. Herrera V, Yeh E, Murphy K, Parsonnet J, Banaei N, (2010) Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold In-Tube assay. J Clin Microbiol 48: 2672-2676.
62. Doberne D, Gaur RL, Banaei N, (2011) Preanalytical delay reduces sensitivity of QuantiFERON-TB Gold In-Tube assay for detection of latent tuberculosis infection. J Clin Microbiol pp. 3061-3064.